mutational panel sequenom massarray including akt1, braf, ddr2, egfr, mek1, pik2ca, kras and nras (Sequenom)
90
Structured Review
Sequenom
mutational panel sequenom massarray including akt1, braf, ddr2, egfr, mek1, pik2ca, kras and nras
Mutational Panel Sequenom Massarray Including Akt1, Braf, Ddr2, Egfr, Mek1, Pik2ca, Kras And Nras, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/akt1+e17k+mutation/pmc07881638-81-2-3
Average 90 stars, based on 1 article reviews
Mutational Panel Sequenom Massarray Including Akt1, Braf, Ddr2, Egfr, Mek1, Pik2ca, Kras And Nras, supplied by Sequenom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sequenom+massarray+panel/akt1+e17k+mutation/pmc07881638-81-2-3
Average 90 stars, based on 1 article reviews
mutational panel sequenom massarray including akt1, braf, ddr2, egfr, mek1, pik2ca, kras and nras - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study Article Snippet: A mutational Article Title: AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder Article Snippet: AKT1 rs2494732 genotype was determined by Sequenom (Hamburg, Germany) using the Article Title: AKT1 Moderation of Cannabis-Induced Cognitive Alterations in Psychotic Disorder Article Snippet: AKT1 Genotype AKT1 rs2494732 genotype was determined by Sequenom (Hamburg, Germany) using the Mutagenesis:Article Title: Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle Article Snippet: .. Targeted capture MPS also confirmed the presence of the Article Title: Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology Article Snippet: The last reported mutation is close to the threshold of detection by Sequenom technology. .. Finally, the last, fourth, sample showed Article Title: Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle Article Snippet: .. Targeted capture MPS also confirmed the presence of the Article Title: INVITED ABSTRACTS Article Snippet: Preliminary data are available for 16 patients: AKT1 E17 mutation by Sequenom (N=1), MGMT loss by IHC (N=1); and PTEN loss by IHC (N=2). .. Preliminary data are available for 16 patients: Clinical Proteomics:Article Title: Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle Article Snippet: .. Targeted capture MPS also confirmed the presence of the Next-Generation Sequencing:Article Title: Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology Article Snippet: The last reported mutation is close to the threshold of detection by Sequenom technology. .. Finally, the last, fourth, sample showed Polymerase Chain Reaction:Article Title: A novel AKT3 mutation in melanoma tumours and cell lines Article Snippet: .. Polymerase chain reaction (PCR) and Immunohistochemistry:Article Title: INVITED ABSTRACTS Article Snippet: Preliminary data are available for 16 patients: AKT1 E17 mutation by Sequenom (N=1), MGMT loss by IHC (N=1); and PTEN loss by IHC (N=2). .. Preliminary data are available for 16 patients: |